Alteration of MDM2 by the Small Molecule YF438 Exerts Antitumor Effects in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Alteration of MDM2 by the Small Molecule YF438 Exerts Antitumor Effects in Triple-Negative Breast Cancer

Published:2021-05-13 Issue:15 Volume:81 Page:4027-4040
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Shan Peipei,Yang Feifei,Qi Hongzhao,Hu Yunjie,Zhu Sujie,Sun Zhenqing,Zhang Zhe,Wang Chuanxiao,Hou Caixia,Yu Jie,Wang Lirong,Zhou Zhixia,Li Peifeng,Zhang Hua^ORCID,Wang Kun

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Qingdao science and technology

Qingdao Municipal Medical Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HTB50-2 Inhibits Growth and Migration of Triple-negative Breast Cancer via FOSL2/FOXC1 Signaling Axis and Subsequent Ferroptosis;Current Medicinal Chemistry;2024-08-09

2. Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy;Cell Communication and Signaling;2024-07-15

3. Triterpenoids with α-glucosidase inhibitory and cytotoxic activities from the fruits of Schisandra chinensis;Fitoterapia;2024-07

4. CRISPR Double Knockout Library Reveals Synthetic Lethal Gene Pairs in Triple-Negative Breast Cancer;2024-05-17

5. First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway;Acta Pharmaceutica Sinica B;2024-05